Evidence map›Paper›PMID 28924365›Full record

ArticleInternational journal of medical sciences2017

Effects of Hypobaric Hypoxia on Rat Retina and Protective Response of Resveratrol to the Stress.

Xiaorong Xin, Hong Dang, Xiaojing Zhao, Haohao Wang

Open access · goldAbstract read
In one paragraph

Article in International journal of medical sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Hypobaric hypoxia triggers pyroptosis in the retina via NLRP3 inflammasome activation.Apoptosis : an international journal on programmed cell death · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Xiaorong XinDepartment of Ophthalmology, Qinghai Red Cross Hospital, Xining, Qinghai, China.
Hong DangDepartment of Ophthalmology, Qinghai Red Cross Hospital, Xining, Qinghai, China.
Xiaojing ZhaoDepartment of Ophthalmology, Qinghai Red Cross Hospital, Xining, Qinghai, China.
Haohao WangDepartment of Ophthalmology, Qinghai Red Cross Hospital, Xining, Qinghai, China.
Qinghai Red Cross Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-altitude retinopathy represents retinal functional changes associated with environmental challenges imposed by hypobaric hypoxia, but the detailed cellular and molecular mechanism underlying this process remains unclear. Our current investigation was to explore the effect of hypobaric hypoxia on the rat retina and determine whether resveratrol has a protective efficacy on the hypoxic damage to the retina. Experiment rats were randomly grouped as the control group, hypoxia group and resveratrol intervention group. The hypoxia group and the resveratrol intervention group were maintained in a low-pressure oxygen cabin, and the resveratrol intervention group was given daily intraperitoneal injections with resveratrol. We found that hypobaric hypoxia increased thioredoxin 1 (Trx1) and thioredoxin 2 (Trx2) expression in retinas, and resveratrol treatment significantly reversed these changes (

Indexed as

Altitude SicknessAnimalsAntioxidantsApoptosisCytokinesDisease Models, AnimalHumansMaleOxidative StressRatsRats, Sprague-DawleyResveratrolRetinaRetinal DiseasesStilbenesThioredoxinsAntioxidantsCytokinesResveratrolStilbenesThioredoxinsTxn1 protein, ratTxn2 protein, ratCaspaseHeat shock proteinHypobaric hypoxiaHypoxia-inducible factor-1.ResveratrolRetina

Identifiers

PMID28924365
PMCPMC5599917
OpenAlexW2754462819

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.